Thermedical

Thermedical is a clinical-stage medical device company pioneering a novel thermal ablation platform for oncology and cardiology applications. Its core technology, SereneRF, utilizes low-flow, low-temperature radiofrequency energy to create large, predictable, and conformal ablation zones, potentially addressing limitations of existing ablation methods. The company is initially targeting challenging soft tissue tumors, such as pancreatic cancer, and cardiac arrhythmias like ventricular tachycardia. As a private, pre-revenue entity, Thermedical's progress hinges on successful clinical validation and strategic partnerships to advance its pipeline.

SereneRF (Saturated Steam Enabled Radiofrequency) ablation platform. A low-flow, low-temperature catheter-based system that uses convective heating via a stable steam bubble to create large, predictable, and conformal thermal ablation zones in tissue.

In tumor ablation, competitors include established radiofrequency (e.g., Medtronic, Boston Scientific), microwave (e.g., AngioDynamics), and cryoablation (e.g., BTG) systems. In cardiac ablation, the market is dominated by Johnson & Johnson (Biosense Webster) and Abbott, with novel technologies like pulsed-field ablation emerging. Thermedical's key differentiator is its unique low-temperature steam-based mechanism aimed at creating more predictable and larger lesions, particularly in vascularized tissues.